Exact Mass: 705.3757774000001

Exact Mass Matches: 705.3757774000001

Found 80 metabolites which its exact mass value is equals to given mass value 705.3757774000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Fumonisin B2

2-[2-({19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-16,18-dihydroxy-5,9-dimethylicosan-7-yl}oxy)-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935354)


Fumonisin B2 is from Fusarium moniliforme Fumonisin B2 is a fumonisin mycotoxin produced by the fungi Fusarium verticillioides and Fusarium moniliforme. It is a structural analog of fumonisin B1. Fumonisin B2 is more cytotoxic than fumonisin B1. Fumonisin B2 inhibits sphingosine acyltransferase D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D037341 - Fumonisins D009676 - Noxae > D002273 - Carcinogens From Fusarium moniliforme

   

Fumonisin B3

2-[2-({19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-11,18-dihydroxy-5,9-dimethylicosan-7-yl}oxy)-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935354)


D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D037341 - Fumonisins Fumonisin B3 is from Fusarium moniliforme. D009676 - Noxae > D002273 - Carcinogens From Fusarium moniliforme

   

Zankiren

2-({2-benzyl-1-hydroxy-3-[(4-methylpiperazin-1-yl)sulphonyl]propylidene}amino)-N-(1-cyclohexyl-3,4-dihydroxy-6-methylheptan-2-yl)-3-(1,3-thiazol-4-yl)propanimidic acid

C35H55N5O6S2 (705.359357)


   

gamma-Secretase Inhibitor II

4-({2-[(2-{[(tert-butoxy)(hydroxy)methylidene]amino}-1-hydroxy-3-methylbutylidene)amino]-1-hydroxy-3-methylpentylidene}amino)-2,2-difluoro-N-{1-[(1-methoxy-3-methyl-1-oxopentan-2-yl)-C-hydroxycarbonimidoyl]-2-methylpropyl}-3-oxopentanimidate

C33H57F2N5O9 (705.4124136)


   
   

Alanylthreonyltryptophanyl-leucylaspartylthreonine

Alanylthreonyltryptophanyl-leucylaspartylthreonine

C32H47N7O11 (705.3333392)


   
   
   

2-[2-[(5R,6R,7S,9S,11R,18S,19S)-19-amino-6-[(3R)-3,4-dicarboxybutanoyl]oxy-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

NCGC00380841-01!2-[2-[(5R,6R,7S,9S,11R,18S,19S)-19-amino-6-[(3R)-3,4-dicarboxybutanoyl]oxy-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935354)


   

(2S)-2-[2-[(5R,6R,7S,9S,16R,18S,19S)-19-amino-6-[(3S)-3,4-dicarboxybutanoyl]oxy-16,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

NCGC00347714-02!(2S)-2-[2-[(5R,6R,7S,9S,16R,18S,19S)-19-amino-6-[(3S)-3,4-dicarboxybutanoyl]oxy-16,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935354)


   

(2S)-2-[2-[(5R,6R,7S,9S,16R,18S,19S)-19-amino-6-[(3S)-3,4-dicarboxybutanoyl]oxy-16,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

(2S)-2-[2-[(5R,6R,7S,9S,16R,18S,19S)-19-amino-6-[(3S)-3,4-dicarboxybutanoyl]oxy-16,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935354)


   

fumonisin B2

1,1-[(1S,2R)-1-[(2S,9R,11S,12S)-12-amino-9,11-dihydroxy-2-methyltridecyl]-2-[(1R)-1-methylpentyl]-1,2-ethanediyl]ester-1,2,3-propanetricarboxylic acid

C34H59NO14 (705.3935354)


A fumonisin that is (2S,3S,12S,14S,15R,16R)-2-amino-12,16-dimethylicosane-3,14,15-triol in which the hydroxy groups at positions 14 and 15 have each been esterified by condensation with the 1-carboxy group of 3-carboxyglutaric acid (giving a 3-carboxyglutarate ester group with R configuration in each case). D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D037341 - Fumonisins D009676 - Noxae > D002273 - Carcinogens CONFIDENCE standard compound; INTERNAL_ID 5969 CONFIDENCE Reference Standard (Level 1)

   

Fumonisin B3

2-[2-[(5R,6R,7S,9S,11R,18S,19R)-19-amino-6-(3,4-dicarboxybutanoyloxy)-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935354)


D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D037341 - Fumonisins D009676 - Noxae > D002273 - Carcinogens CONFIDENCE isolated standard

   

OHDdiA-PE

1-(9Z-octadecenoyl)-2-(9-hydroxy-11-carboxy-10E-undecenoyl)-sn-glycero-3-phosphoethanolamine

C35H64NO11P (705.4216764)


   

PKODA-PS

1-hexadecanoyl-2-(9,12-dioxo-10E-dodecenoyl)-sn-glycero-3-phosphoserine

C34H60NO12P (705.385293)


   

4-Hepten-3-one, 5-hydroxy-2,2,6,6-tetramethyl-, europium(3+) salt, (4E)-

4-Hepten-3-one, 5-hydroxy-2,2,6,6-tetramethyl-, europium(3+) salt, (4E)-

C33H60EuO6 (705.3602089999999)


   
   

N-(2-aminophenyl)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]heptanediamide

N-(2-aminophenyl)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]heptanediamide

C42H51N5O5 (705.3889995999999)


   

(9Z)-17-hydroxyoctadec-9-enoate 17-O-diacetylsophoroside

(9Z)-17-hydroxyoctadec-9-enoate 17-O-diacetylsophoroside

C34H57O15- (705.3697272)


   
   
   
   
   

PI-Cer 16:3;2O/12:1;O

PI-Cer 16:3;2O/12:1;O

C34H60NO12P (705.385293)


   

PI-Cer 15:3;2O/13:1;O

PI-Cer 15:3;2O/13:1;O

C34H60NO12P (705.385293)


   

PI-Cer 14:3;2O/14:1;O

PI-Cer 14:3;2O/14:1;O

C34H60NO12P (705.385293)


   

2-amino-3-[[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C38H60NO9P (705.400548)


   
   

2-[2-[(5R,6R,7S,9S,11R,18S,19S)-19-amino-6-[(3R)-3,4-dicarboxybutanoyl]oxy-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

2-[2-[(5R,6R,7S,9S,11R,18S,19S)-19-amino-6-[(3R)-3,4-dicarboxybutanoyl]oxy-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid

C34H59NO14 (705.3935354)


   

(2S)-2-amino-3-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C37H56NO10P (705.3641646)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(e,2e,4e,9e)-n-[(1e)-2-[({5-benzyl-3,6,9-trihydroxy-14,14-dimethyl-15-oxo-1,4,7,10,13-pentaazabicyclo[10.2.1]pentadeca-3,6,9-trien-8-yl}methyl)-c-hydroxycarbonimidoyl]eth-1-en-1-yl]-13-hydroxytetradeca-2,4,9-trienimidic acid

(e,2e,4e,9e)-n-[(1e)-2-[({5-benzyl-3,6,9-trihydroxy-14,14-dimethyl-15-oxo-1,4,7,10,13-pentaazabicyclo[10.2.1]pentadeca-3,6,9-trien-8-yl}methyl)-c-hydroxycarbonimidoyl]eth-1-en-1-yl]-13-hydroxytetradeca-2,4,9-trienimidic acid

C37H51N7O7 (705.3849776)